Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.
With advanced orthopaedic and cartilage-care infrastructure, Medanta - The Medicity offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 2009, the JCI, NABH hospital is located in Gurgaon, India, and has 1250 beds.
ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.
Phyathai 2 International Hospital provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 1987, the JCI hospital is based in Bangkok, Thailand, with 550 beds and services for domestic and international patients.
During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.
ParkCity Medical Centre provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 2012, the JCI hospital is based in Kuala Lumpur, Malaysia, with 300 beds and services for domestic and international patients.
During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.
Florence Nightingale Hospital offers advanced Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration techniques and internationally accepted treatment protocols. Established in 1989, the JCI hospital is located in Istanbul, Turkey, with 804 beds and provides specialised orthopaedic care for local and international patients.
ACI is a cartilage restoration procedure used to treat selected focal cartilage defects, particularly in the knee. Healthy cartilage cells are collected from the patient's joint, expanded in a laboratory, and later implanted into the damaged area. The orthopaedic specialist evaluates the size and location of the cartilage defect, joint stability, and overall knee health before treatment.
Parkway East Hospital offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 1942, the JCI hospital is situated in Singapore, Singapore, with 143 beds, serving local and international patients.
ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.
With advanced orthopaedic and cartilage-care infrastructure, Krabi Nakharin International Hospital offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 1997, the JCI hospital is located in Krabi, Thailand, and has 150 beds.
ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.
Subang Jaya Medical Centre offers advanced Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration techniques and internationally accepted treatment protocols. Established in 1985, the JCI hospital is located in Kuala Lumpur, Malaysia, with 442 beds and provides specialised orthopaedic care for local and international patients.
ACI is a cartilage restoration procedure used to treat selected focal cartilage defects, particularly in the knee. Healthy cartilage cells are collected from the patient's joint, expanded in a laboratory, and later implanted into the damaged area. The orthopaedic specialist evaluates the size and location of the cartilage defect, joint stability, and overall knee health before treatment.
At Saudi German Hospital, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 2012, the JCI hospital is located in Dubai, United Arab Emirates, and has 300 beds.
ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.
Yanhee International Hospital offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 1984, the ISO, JCI hospital is situated in Bangkok, Thailand, with 400 beds, serving local and international patients.
ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.
With advanced orthopaedic and cartilage-care infrastructure, Antalya Anadolu Hastanesi offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 2006, the hospital is located in Antalya, Turkey, and has 114 beds.
ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.
Canadian Specialist Hospital provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 2006, the JCI hospital is based in Dubai, United Arab Emirates, with 200 beds and services for domestic and international patients.
During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.
With advanced orthopaedic and cartilage-care infrastructure, Turan and Turan Clinic offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 1999, the JCI hospital is located in Bursa, Turkey, and has 225 beds.
ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.
Max Hospital, Gurgaon offers advanced Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration techniques and internationally accepted treatment protocols. Established in 2007, the ISO, NABH, NABL hospital is located in Gurgaon, India, with 104 beds and provides specialised orthopaedic care for local and international patients.
ACI is a cartilage restoration procedure used to treat selected focal cartilage defects, particularly in the knee. Healthy cartilage cells are collected from the patient's joint, expanded in a laboratory, and later implanted into the damaged area. The orthopaedic specialist evaluates the size and location of the cartilage defect, joint stability, and overall knee health before treatment.
Sikarin Hospital offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 1979, the JCI hospital is situated in Bangkok, Thailand, with 354 beds, serving local and international patients.
ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.
Istanbul, Turkey
Istinye University Medical Park Gaziosmanpasa Hospital provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 2015, the ISO, JCI hospital is based in Istanbul, Turkey, with 197 beds and services for domestic and international patients.
During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.